老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Larimar Therapeutics, Inc.

3.12
-0.4300-12.11%
成交量：272.69万
成交额：904.62万
市值：2.67亿
市盈率：-1.60
高：3.56
开：3.56
低：3.12
收：3.55
52周最高：6.91
52周最低：1.61
股本：8,559.04万
流通股本：4,514.94万
量比：1.47
换手率：6.04%
股息：- -
股息率：- -
每股收益(TTM):-1.9534
每股收益(LYR):-1.3159
净资产收益率：-78.24%
总资产收益率：-42.99%
市净率：1.92
市盈率(LYR):-2.37

数据加载中...

总览公司新闻资讯公告
2020/08/06

重要事件披露

8-K - Current report
2020/07/13

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/30

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/26

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/26

重要事件披露

8-K/A [Amend] - Current report
2020/06/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/08

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/06/08

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/06/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/06/03

重要事件披露

8-K - Current report
2020/06/02

重要事件披露

8-K - Current report
2020/05/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/04/27

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/24

重要事件披露

8-K - Current report
2020/04/10

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/09

重要事件披露

8-K - Current report
2020/03/05

重要事件披露

8-K - Current report
2020/03/05

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/03/05

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
更多